Curis
CRIS
#11023
Rank
ยฃ0.5 M
Marketcap
ยฃ0.26
Share price
-17.89%
Change (1 day)
-80.84%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -ยฃ5.06 Million

According to Curis's latest financial reports the company's current earnings are ยฃ7.06 Million. In 2025 the company made an earning of -ยฃ4.05 Million, an increase over its 2024 earnings that were of -ยฃ32.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ5.06 Million25.11%
2025 -ยฃ4.05 Million-87.38%
2024 -ยฃ32.03 Million-5.77%
2023 -ยฃ33.99 Million-13.1%
2022 -ยฃ39.11 Million27.52%
2021 -ยฃ30.67 Million65.09%
2020 -ยฃ18.58 Million-9.1%
2019 -ยฃ20.44 Million-4.73%
2018 -ยฃ21.45 Million-41.95%
2017 -ยฃ36.95 Million-14.37%
2016 -ยฃ43.15 Million3.55%
2015 -ยฃ41.67 Million271.52%
2014 -ยฃ11.22 Million76.64%
2013 -ยฃ6.35 Million
2011 -ยฃ5.4 Million27.76%
2010 -ยฃ4.23 Million-43.87%
2009 -ยฃ7.53 Million-23.44%
2008 -ยฃ9.83 Million56.66%
2007 -ยฃ6.27 Million-16.71%
2006 -ยฃ7.53 Million-36.92%
2005 -ยฃ11.94 Million156.25%
2004 -ยฃ4.66 Million-37.24%
2003 -ยฃ7.43 Million-93.34%
2002 -ยฃ0.12 Billion86.79%
2001 -ยฃ59.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.92 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.18 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ46.33 Million 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.75 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.24 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ16.62 Million 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ44.24 M-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA